Glaucoma

The development of laser technology over the last few years has improved vision for many people.
At the Ophthalmos Research & Educational Institute we are using the latest laser technology with the aim of dramatically reducing Intraocular pressure. This method in medical terms is called S.L.T., the Selective Laser Trabeculoplasty. For some patients this treatment comes as a welcome solution to their problem, when the use of anti-glaucoma drops are ineffective, causing poor quality of vision.

The development of laser technology over the last few years has improved vision for many people. At the Ophthalmos Research & Educational Institute we are using the latest laser technology with the aim of dramatically reducing Intraocular pressure. This method in medical terms is called S.L.T., the Selective Laser Trabeculoplasty. For some patients this treatment comes as a welcome solution to their problem, when the use of anti-glaucoma drops are ineffective, causing poor quality of vision.

Glaucoma is a disease of the eye that could potentially damage the optic nerve and is related to the increase in intraocular pressure. When left untreated glaucoma will cause gradual loss of peripheral vision and progress to the central vision. When the intraocular pressure cannot be controlled by drops or S.L.T. Laser, then a Trabeculectomy is necessary.

This operation involves the creation of a flap valve, on the white of the eye under the lid. This canal allows the fluid to flow, in a controlled manner to reduce the pressure. With this method the fluid is absorbed by the white of the eye.

There are advantages using the new technology S.L.T., the Selective Laser Trabeculoplasty, in comparison with previous techniques. The use of drops may dramatically be decreased or even discontinued. Drops used for the treatment of glaucoma often cause irritation and other undesirable side effects, as opposed to the use of the S.L.T. Laser technology, which protects and reduces the possibilities of such effects and the loss of vision.